Comment on Merck faces J&J rights snag

Merck faces J&J rights snag

Johnson & Johnson, the US pharmaceuticals group, has one month to decide whether to try to claim back full rights over two pivotal medicines as a result of Merck's $41bn planned takeover of Schering Plough

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News